Health & Science

The first human test of stem cells; Why bees are dying in droves; Down-facing dogs; How screen time hurts kids; Sweating out the vote

The first human test of stem cells

Can stem cells heal damaged spinal cords and enable paralyzed people to walk again? In the first clinical test of its kind, says USA Today, surgeons have injected embryonic stem cells into the spinal cord of a paralyzed patient in the hope that it will regenerate broken neural connections. Stem cells are master cells that can give rise to more than 200 types of human tissue and so offer tremendous potential in treating disease and tissue damage. Embryonic stem cells are harvested from embryos created as a result of fertility treatments; their use has been embroiled in ethical debate. In the new trial, privately funded by the Geron Corporation, surgeons at the Shepherd Center in Atlanta are treating a recently paralyzed patient’s damaged spinal cord with millions of stem cells, to see if the cells travel to the site of the injury and grow into spinal sheath cells capable of transmitting neural signals. Similar treatments in rats have shown partial success. Researchers expect no miracles; this first trial is primarily aimed at testing the treatment’s safety. But after years of controversy, the human trial “is a major morale boost for scientists, clinicians, and most of all patients,’’ says regenerative-medicine expert Chris Mason. The test, he says, “marks the dawn of the ‘stem-cell age.’’’

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us